Specific features of ß-catenin-mutated hepatocellular carcinomas
Open Access
- 11 September 2024
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 131 (12) , 1871-1880
Abstract
CTNNB1, encoding the ß-catenin protein, is a key oncogene contributing to liver carcinogenesis. Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer in adult, representing the third leading cause of cancer-related death. Aberrant activation of the Wnt/ß-catenin pathway, mainly due to mutations of the CTNNB1 gene, is observed in a significant subset of HCC. In this review, we first resume the major recent advances in HCC classification with a focus on CTNNB1-mutated HCC subclass. We present the regulatory mechanisms involved in β-catenin stabilisation, transcriptional activity and binding to partner proteins. We then describe specific phenotypic characteristics of CTNNB1-mutated HCC thanks to their unique gene expression patterns. CTNNB1-mutated HCC constitute a full-fledged subclass of HCC with distinct pathological features such as well-differentiated cells with low proliferation rate, association to cholestasis, metabolic alterations, immune exclusion and invasion. Finally, we discuss therapeutic approaches to target ß-catenin-mutated liver tumours and innovative perspectives for future drug developments.Keywords
Funding Information
- Fondation pour la Recherche Médicale (DEQ20180839586)
- Ligue Contre le Cancer (EAC, Comités Gironde et Charentes)
- Association Française d'Etude du Foie
- Conseil Régional Aquitaine (PhD fellowship)
- SIRIC BRIO
- Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche (PhD fellowship)
- Fondation ARC pour la Recherche sur le Cancer
- Université de Bordeaux
- Association Française d'Etude du Foie
This publication has 102 references indexed in Scilit:
- Activation of β-catenin provides proliferative and invasive advantages in c-myc /TGF-α hepatocarcinogenesis promoted by phenobarbitalCarcinogenesis, 2004
- Hepatocarcinogenesis in Mice with β-Catenin and Ha-Ras Gene MutationsCancer Research, 2004
- New targets of β-catenin signaling in the liver are involved in the glutamine metabolismOncogene, 2002
- Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.2002
- Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of β-catenin-mutated mouse liver tumorsOncogene, 2001
- β-catenin mutation and overexpression in hepatocellular carcinomaCancer, 2001
- Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesisGastroenterology, 2001
- Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.2001
- AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1Nature Genetics, 2000
- Effects of Fetal Calf Serum and Disruption of Cadherin Function on the Formation of Bile Canaliculi between HepatocytesExperimental Cell Research, 1994